A novel antioxidant polysaccharide-peptide complex LB-1b from the fruiting bodies of the edible abalone mushroom (Pleurotus abalonus) was purified and identified. The structural characteristic of LB-1b was identified by FTIR (Fouriertransform IR), 13 C NMR and 1 H NMR spectroscopy. LB-1b is a polysaccharide-peptide complex that contains glucose, rhamnose, glucuronic acid and galactose in the molar ratio of 22.4:1:1.7:1.6 and the N-terminal sequence of its peptide moiety has also been determined. The N-terminal amino acid sequence of LB-1b, IPKERKEFQQAQHLK, showed some resemblance to antioxidant enzymes. LB-1b exhibited high antioxidant activity in erythrocyte haemolysis in vitro and the anti-proliferative activity towards hepatoma HepG2 cells and breast cancer MCF7 cells with an IC 50 of 24 and 14 μM respectively. LB-1b also demonstrated hypoglycaemic activity in drug-induced diabetic mice and anti-HIV-1 RT (reverse transcriptase) with an IC 50 value of 12.5 μM.
INTRODUCTION
As a health food, edible mushrooms are welcomed by people all over the world because they are low in calories and high in vegetable proteins, vitamins, iron, chitin, fibre and minerals. Mushrooms are becoming more and more important in our diet owing to their nutritional, organoleptic and pharmacological characteristics [1, 2] . The tonic and medicinal value of mushrooms has been used in folk medicine [3] .
Recently, much attention has been paid to the therapeutic value of mushroom such as antioxidative, antitumour, immunomodulating, antiviral, hypocholesterolaemic and hepatoprotective activities [4, 5] . More and more investigators have shown interest in isolating and characterizing new functional compounds from mushrooms, such as polysaccharides [6] , terpenoids [7] , polysaccharide-peptide complexes [8] and proteins [9] . For in- Abbreviations used: AAPH, 2,2-azobis-(2-amidinopropane) dihydrochloride; BHA, butylated hydroxyanisole; FTIR, Fourier-transform IR; MTT, 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide; PAS, periodic acid-Schiff; PSPC, polysaccharide-protein complex; ROS, reactive oxygen species; RT, reverse transcriptase. 1 Correspondence may be addressed to either of these authors (email b021770@mailserv.cuhk.edu.hk or liufang312@nankai.edu.cn).
stance, an extract from the winter mushroom displayed antioxidant activity [10] .
Pleurotus is one of the most widely cultivated and consumed edible mushroom genus in the world and species are generally called oyster mushrooms because the pileus or cap is shell-like and the stipe is eccentric or lateral [11, 12] . The genus Pleurotus has 40 species of which P. florida, P. sajor-caju, P. ostreatus and P. abalonus are commonly available edible mushrooms [13] . The fruiting bodies of Pleurotus species have a characteristic texture and a pleasant flavour that makes them popular as culinary mushrooms worldwide [14] . Extracts or compounds isolated from fermentation of broth, mycelia and fruiting bodies of various Pleurotus species have been shown to possess a number of medicinal properties, such as antitumour [15] , immunomodulatory [16] , antioxidant [17, 18] , anti-inflammatory [19] , antihyperlipidaemic [20] , antimicrobial [21] and antiviral activities [22] . The aqueous extract of P. ostreatus exerted antioxidant [23] anti-proliferative and pro-apoptotic effects on HT-29 colon cancer cells [24] and alcoholic extracts of P. citrinopileatus fruit bodies, mycelia and filtrate from submerged culture also exhibited an antioxidative action [20] . In particular, polysaccharides appear to display potent antitumour and immuno-enhancing activities. The immuno-enhancing activities of polysaccharide-peptide complex and PSPC (polysaccharide-protein complex) from mushrooms have been reported [25, 26] . However, the biochemical mechanisms of these therapeutic activities remain largely unknown. P. abalonus belongs to the family Pleurotaceae and order Agaricales of the Basidiomycetes and is characterized by its black-headed coremioid imperfect state that is seen on the edges and faces of the lamellae. Only a few studies on the biological activity of the active substance in P. abalonus have been reported. An earlier study exhibited that the methanolic extract of P. abalonus showed higher antioxidant activity and free radical scavenging ability than winter and shiitake mushrooms [18] . However, no study on the identification of PSPC in the fruit body of P. abalonus has yet been conducted. In the previous work, the extracts of 37 edible fungi were screened for antioxidant activity in vitro systems (results not shown). Among the tested fungi, P. abalonus showed strong antioxidant activity.
The goal of the present study was to find an efficient method to purify the polysaccharide-peptide in the fruit body of P. abalonus and identify its structural characteristics which will contribute to a better understanding of the relationships among the antioxidant, antiproliferative, antidiabetic and antiviral biological activities.
MATERIALS AND METHODS

Materials
Dried abalone mushroom (P. abalonus) was purchased from a local market. Affi-Gel Blue was purchased from Bio-Rad, DEAEcellulose 32 was purchased from Sigma and Sephadex G-200 was from GE Healthcare. AAPH [2,2-azobis-(2-amidinopropane) dihydrochloride] was purchased from Aldrich Chemicals, and Dextran-Blue 2000 was from Sigma. All other chemicals used were of reagent grade.
Isolation and purification of the samples
Dried fruiting bodies of the mushroom were cleaned, dried and crushed before soaking in distilled water overnight at room temperature (22
• C) and then boiling in distilled water for 3 h at 100
• C. After the removal of debris by filtration, the filtrate was concentrated in a rotary evaporator. Four volumes of ethanol were added to the extract and the mixture was allowed to stand overnight at 25
• C. The precipitate was collected and freeze-dried to yield the sample named P.
P was dissolved in 10 mM Tris/HCl buffer (pH 7.4) and chromatographed on a 2.5 cm × 50 cm column of DEAE-cellulose. The active adsorbed fraction named L was eluted with 1 mol/l NaCl. L was chromatographed on a 2.0 cm × 100 cm column of Sephadex G-200 in distilled water and two fractions (LA and LB) were collected. LB was separated on a 5 cm × 10 cm column of Affi-Gel Blue gel in 10 mM Tris/HCl buffer (pH 7.4). The unadsorbed fraction was collected as LB-1. The fractions that were eluted with 10 mM Tris/HCl buffer (pH 7.4) containing 1 mM NaCl were named LB-2 and LB-3 respectively. Finally, LB-1 was chromatographed on a column of Superdex 75 by FPLC and two fractions, LB-1a and LB-1b, were collected.
SDS/PAGE
SDS/PAGE was carried out following the procedure of Sambrook et al. [27] . At the end of electrophoresis, the gel was stained with Coomassie Brilliant Blue. The molecular mass of LB-1b was determined by comparison of its electrophoretic mobility with those of molecular mass marker proteins. Then the gel was stained with PAS (periodic acid -Schiff) dye to detect glycogen in LB-1b.
Polysaccharide contents and monosaccharide analysis
The carbohydrate content of LB-1b was determined with the anthrone/sulfuric acid colorimetric method using glucose as the standard [28] .
Derivatization of monosaccharide was performed as described by Honda et al. [29] . LB-1b (20 mg) was hydrolysed in 2.0 ml of 1 mol/l sulfuric acid at 100
• C for 6 h. Then 2 mol/l NaOH was added to adjust the pH to 7.0, and then distilled water was added to dilute the mixture to 5.0 ml. The mixture was centrifuged, and 80 μl of the supernatant was added to 80 μl of 0.25 mol/l of 1-(2-chlorophenyl)-3-methyl-2-pyrazolin-5-one (dissolved in methanol) and 80 μl of 0.2 mol/l NaOH. After the mixture had been incubated at 70
• C for 30 min, the pH was adjusted to 7.0 with 0.2 mol/l HCl. The mixture was extracted with 0.5 ml of isoamyl acetate, and the organic phase was discarded. Chloroform (0.5 ml) was added for re-extraction. The aqueous phase was chromatographed on a C 18 column (250 mm × 4.6 mm, 5 μm). The mobile phases A and B were 15 % (v/v) acetonitrile with 20 mM ammonium acetate and 40 % (v/v) acetonitrile with 20 mM ammonium acetate respectively. From 0 to 25 min, the mobile phase B was changed from 0 % to 50 % (v/v). The wavelength for monitoring the column effluent was 250 nm and the flow rate was 1 ml/min at 25
• C.
Protein contents and amino acid analysis
The protein concentration of LB-1b was determined by the method of Lowry et al. [30] with BSA as standard. Amino acids in LB-1b were determined with a Biochrom 20 amino acid analyser (Pharmacia, Fullerton, CA, U.S.A.) using an acid hydrolysis and ninhydrin detection procedure. The hydrolysis of LB-1b (5 mg) was performed with 1 ml of 6 mol/l HCl containing 5 mg/ml of phenol in a sealed ampoule for 24 h at 110
• C. The hydrolysate was evaporated and the dried residue 
N-terminal amino acid sequence and HPLC analysis of LB-1b
The N-terminal amino acid sequence of LB-1b was analysed by means of automated Edman degradation using a Hewlett Packard 1000A protein sequencer equipped with an HPLC system. LB-1b was chromatographed on a TSK column (250 mm × 4.6 mm) (TSK Wxl b ; Shimadzu, Japan). The mobile phase was 0.1 mol/l PBS and 0.3 mol/l NaCl (pH 7.0). The wavelength used for monitoring the absorbance of the effluent was 230 nm and the flow rate was 1 ml/min at 25
Structural characterization by FTIR (Fouriertransform IR) spectroscopy, 13 C NMR and 1 H NMR spectroscopy LB-1b was analysed by transmittance IR spectroscopy in the form of KBr disks using a PerkinElmer Spectrum 1000 FTIR spectrometer.
1 H and 13 C NMR spectra of the sample in 2 H 2 O were recorded at ambient temperature using a Varian Associates Unity 500 spectrometer that was operated at 500 MHz for 1 H and 125.8 MHz for 13 C.
Assay of inhibition of erythrocyte haemolysis
All animal procedures were approved by the Nankai University Ethics Committee. The mice were anaesthetized by diethyl ether before the experiment. Blood was obtained from mice by extirpating their eyeballs and collected in tubes containing 0.15 M NaCl. Erythrocytes were separated from plasma and the buffy coat, and washed three times with 10 vol. of 0.15 mol/l NaCl. During the last wash, the erythrocytes were centrifuged at 690 g for 10 min to obtain a constantly packed cell preparation [31] . Erythrocyte haemolysis was mediated by peroxyl radicals in the assay system [32] . A 10 % suspension of erythrocytes in PBS (pH 7.4) was added to the same volume of 200 mM AAPH solution (in PBS) containing samples to be tested. After the reaction mixture had been shaken gently at 37
• C for 1 h, an aliquot of the mixture was diluted with 8 vol. of PBS, and centrifuged at 690 g for 10 min. Absorbance (A) of the supernatant was read at 540 nm. Similarly, another aliquot of the reaction mixture was treated with 8 vol. of distilled water to achieve complete haemolysis, and the absorbance (B) of the supernatant obtained at 540 nm after centrifugation. The percentage of haemolysis was calculated by the equation: haemolysis (%) = (1 − A/B) × 100 %. L-Ascorbic acid was used as a positive control.
Assay of antiproliferative activity on tumour cell lines
The assay of the antiproliferative activity of LB-1b was carried out by testing its inhibition on the growth of the human breast cancer cell line MCF7 and the human hepatoma cell line HepG2. MCF7 and HepG2 were separately suspended in RPMI 1640 medium and the cell density adjusted to 2 × 10 4 cells/ml. A 100 μl of aliquot of the cell suspension was seeded to a well of a 96-well plate, followed by incubation for 4 h. Different concentrations of LB-1b in 100 μl of complete RPMI 1640 medium were then added to the wells and incubated for 24 or 48 h. After 24 or 48 h, 20 μl of a 5 mg/ml of solution of MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] in PBS was spiked into each well, and the plates were incubated for 4 h. The plates were then centrifuged at 324 g for 5 min. The supernatant was carefully removed and 150 μl of DMSO was added to each well to dissolve the formazan at the bottom of the wells. After 10 min, the absorbance was measured at 590 nm by using a microplate reader [33] .
Assay for HIV RT (reverse transcriptase) inhibitory activity
The ability of LB-1b to inhibit HIV-1 RT was assessed by an ELISA kit from Boehringer Mannheim as described by Collins et al. [34] .
Assay of hypoglycaemia activity
Normal male Kunming mice were randomly divided into three groups (15 mice in each group) and were named CT (diabetic control), treated with BHA (butylated hydroxyanisole) and LB1b (treated with LB-1b) respectively. The mice in LB-1b group, BHA group and CT group were treated with LB-1b (1 mg/kg), BHA (1 mg/kg) and 0.9 % NaCl (1 mg/kg) orally by gavage for 10 days (i.e. from day 1 to day 10). In this assay, BHA was used as the positive control. On the 10th day, hyperglycaemia was induced by intraperitoneal injection of tetraoxypyrimidine (90 mg/kg). The concentrations of blood glucose level of the mice were tested on the 12th, 16th and 20th days.
Statistical analysis
The average value and S.D. were calculated. To determine whether there were any differences between the activities of samples, data were analysed using the one-way-ANOVA followed by the Tukey test or Students' t test. A value of P < 0.05 was considered to represent a statistically significant difference.
RESULTS
Separation and purification of the active fractions in P. abalonus
Ion-exchange chromatography of the P. abalonus fruiting body extract on DEAE-cellulose produced an adsorbed fraction L with the highest antioxidant activity in the assay of erythrocyte haemolysis inhibition. L was divided into two fractions, LA and LB, on a Sephadex G-200 column (Supplementary Figure S1a at http://www.bioscirep.org/bsr/032/bsr0320221add. htm). Subsequently, LB was chromatographed on Affi-Gel Blue to yield an unadsorbed fraction LB-1 and two adsorbed fractions named LB-2 and LB-3 (Supplementary Figure S1b) . The erythrocyte haemolysis-inhibition activity resided in the unadsorbed fraction LB-1. Finally, LB-1 was separated on Superdex 75 into two fractions, LB-1a and LB-1b (Supplementary Figure S1c) . The erythrocyte haemolysis-inhibition activity was concentrated in fraction LB-1b. The yields of all the fractions and the erythrocyte haemolysis-inhibition activity are shown in Tables 1  and 2 .
Identification of LB-1b
The purified LB-1b appeared as a single band with a molecular mass of 16 kDa on SDS/PAGE. The band was blue when stained with Coomassie Brilliant Blue and red when stained with PAS. It was shown that LB-1b was a PSPC (Supplementary Figure S2 at http://www.bioscirep.org/bsr/ 032/bsr0320221add.htm). LB-1b was chromatographed on a TSK column (Supplementary Figure S3 at http://www. bioscirep.org/bsr/032/bsr0320221add.htm) to yield a single peak indicating that it was a purified compound. The contents of carbohydrate and protein of all the samples are shown in Table 1 . The carbohydrate content of LB-1b was 45.25 + − 1.85 % and the protein content was 53.04 + − 1.03 %, which showed that LB-1b was a complex of polysaccharide and peptide. For the monosaccharide analysis, LB-1b contained glucose, rhamnose, glucuronic acid and galactose in the molar ratio was 22.4:1:1.7:1.6 with glucose being predominant and the amino acid analysis of the LB-1b showed that there were at least 15 kinds of amino acids in LB-1b and eight of them were essential amino acids ( Table 3) .
The N-terminal amino acid sequence of LB-1b was IPKERKE-FQQAQHLK which showed similarity to the amino acid sequence from residue 44 to residue 58 of the 2S storage protein of Brassica rapa and 1.7S seed storage protein of napin-3. Moreover, the N-terminal amino acid sequence of LB-1b showed some resemblance to antioxidant enzymes such as hydroperoxide reductase, thioredoxin peroxidase and thiol peroxidase (Table 4) .
Structural characterization of LB-1b by FTIR, 13 
C NMR and 1 H NMR spectroscopy
In order to determine the functional groups of the purified proteinbound polysaccharide LB-1b, the FTIR spectra were measured in KBr pellets (Figure 1a) . The band at 3404.73 cm − 1 was due to the vibrations of O-H and N-H. The bands in the region of 3000-3600 cm − 1 were due to the vibrations of -COOH. The band corresponding to the ν(C = O) vibrations in the carboxy group at 1635 cm − 1 indicates that this carbonyl group was hydrogenbonded. Furthermore, the ν(C-H) vibrations at 2926.77 cm − 1 together with the ν(C-H) vibrations in the region of 1200-1400 cm − 1 suggested that LB-1b was a kind of polysaccharide. The spectrum of a β-glycosidic bond appeared at approx. 1108 cm − 1 indicating that it was a β-D-linked glucopyranoside.
The 13 C NMR spectrum of the purified peptide bound polysaccharide LB-1b is shown in Figure 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Biological activities of LB-1b
The antiproliferative activity of LB-1b was detected using the MTT dye that was reduced to form blue formazan crystals by mitochondrial dehydrogenase present in living cells. Therefore the MTT assay measures the metabolic activity of the cells and reflects its growth. As shown in Figure 2 , LB-1b exhibited high inhibitory activity on MCF7 cells. At 31.25 μM, the inhibition rate was 84.4 %. LB-1b also showed the inhibitory activity on out by testing the drug-induced diabetic mice. As the antioxidant activity is the criterion for the screening of the extracts from 37 edible mushrooms or P. abalonus, BHA, an antioxidant, was chosen as the positive control. Then 500 μg/ml LB-1b exhibited the highest antioxidant activity in vitro, so 1 mg/kg of body weight was chosen as the dosage given to the mice in vivo due to the problem of drug absorption. When mice were administered orally at the dosage of 1 mg/kg of body weight LB-1b decreased the blood glucose level by 16.6 % and the positive control BHA was 8.32 % (Figure 4) . The blood glucose level of the negative control group CT, which was treated with 0.9 % NaCl, was increased by 1.35 %.
DISCUSSION
The N-terminal amino acid sequence of LB-1b was IPKERKE-FQQAQHLK, which was similar to the 2S storage protein of B. rapa and 1.7S seed storage protein of B. napus named Napin-3. However, it was different from the fungal proteins that have been reported. The storage proteins are a group that comprises proteins generated mainly during seed production and stored in the seed that serve as nitrogen sources for developing embryo during germination. The 2S storage proteins are a major group found in various dicotyledonous plant species that have been shown to be involved in some allergic reactions [35] . The 1.7S storage protein napin is a low-molecular-mass basic protein composed of two disulfide-linked polypeptide chains [36] . There were only a few reports about the antioxidant activity of storage proteins such as the storage protein of sweet potato (Ipomoea batatas Lam.) [37] . There is no information about whether the 2S storage protein of B. rapa and 1.7S seed storage protein of B. napus exhibited antioxidant activity or not. The N-terminal amino acid sequence of LB-1b showed some similarity to antioxidant proteins such as hydroperoxide reductase, thioredoxin peroxidase and thiol peroxidase. Several studies have indicated that oxidative stress plays a significant role in disease development and the outcome of treatment. The excessive generation of ROS (reactive oxygen species) has been thought to contribute to the development of a wide range of diseases including cancer, and the pathologies caused by diabetes [38] . In recent years, the biomaterials with antioxidative activity, especially the antioxidative peptides, have drawn more attention of researchers owing to their low molecular masses, easy absorption and high bioactivity. Many mushroom polysaccharides and polysaccharide-peptides are available in pharmacies as health supplements or for reducing the severity of immunosuppression caused by chemotherapy or radiotherapy [39] . They include PSK, a protein-bound polysaccharide extracted from the mycelia of Coriolus versicolor [40] , the PSPC isolated from the culture filtrate of Tricholoma lobayense [41] and the water-soluble polysaccharides extracted from Ganoderma lucidum. These polysaccharide-peptides or proteins are effective in preventing DNA from strand breakage. It has been shown that the antitumour and immunomodulating activities are strongly related to their antioxidant property [42] . Chemotherapeutic drugs exert their beneficial effect in tumour killing by an increase in ROS generation [43] . In the present study, the LB-1b with antioxidant activity, which is isolated from P. abalonus, also has the anti-proliferative activity towards tumour cells, HepG2 cells and MCF7 cells, with IC 50 values of 24 and 14 μM.
There are many recent reports on the antiviral activities of peptides extracted from fungi. Although HIV, the causative agent of AIDS, was identified more than two decades ago, the disease remains a huge concern for global public health. An oxidative stress occurs in HIV infection even at the early stages of disease. This pro-oxidant state is a result of an imbalance between the generation of ROS and reactive nitrogen species and the antioxidant system, which is responsible for scavenging these oxidants and ensuring that they avoid interacting with cellular targets [44] . Some natural products from fungi such as polysaccharide, peptide and protein which inhibit HIV-1 RT have been identified. For instance, a peptide named SU2 extracted from the fruiting bodies of Russula paludosa shows strong anti-HIV RT activity with an IC 50 value of 11 μM [21] . In the present study, LB-1b showed the inhibition of the RT of HIV-1 at low concentration.
In diabetes, an increased flux of glucose and NEFA (nonesterified fatty acid) is associated with mitochondrial ROS overproduction and as a consequence, increased oxidative stress, which results from an imbalance in redox state in which prooxidants overwhelm antioxidant capacity, and may therefore contribute significantly to disease mechanisms [45] . The polysaccharide Gl-SP extracted from G. lucidum exhibits the potent activity in diabetic mice [46] . The reduction of the blood glucose level was discernible 2-4 days after the injection of the diabetesinducing agent. The blood glucose level could be maintained at a relatively low level for at least 10 days after the induction of diabetes. LB-1b as an antioxidant activity produce exhibited the hypoglycaemic activity in drug-induced diabetic mice. It indicated that the hypoglycaemic activity is associated with the antioxidant activity.
In summary, LB-1b that is isolated from the fruit body of the edible mushroom P. abalonus is a novel 16 kDa polysaccharidepeptide complex. Its N-terminal amino acid sequence shows similarity to the storage proteins and the antioxidant enzymes. The main polysaccharide chain of LB-1b is [→4)-β-D-Glcp-(1→] n . The natural product LB-1b inhibited the proliferation of MCF7 and HepG2 tumour cells, exhibited anti-HIV-1 RT activity and anti-diabetic activity on drug-induced diabetic mice. As all of them are related to the major diseases of people, the results of this study are of great importance. 
